Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Med PaperCAS:MDP -0.08% Net Cash per Share is MAD0.00 as of . 20. The stock has 1 warning sign investors should review. Among 34 Forest Products companies, Med Paper ranks worse than 2941173.53% on this metric.
The historical rank and industry rank for Med Paper's Net Cash per Share or its related term are showing as below:
CAS:MDP's Price-to-Net-Cash is not ranked *
in the Forest Products industry.
Industry Median: 5.485 * Ranked among companies with meaningful Price-to-Net-Cash only.
Med Paper (CAS:MDP) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Med Paper Net Cash per Share Related Terms
Med Paper Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Med Paper's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Paper Net Cash per Share Chart
Med Paper Annual Data
Trend
Net Cash per Share
Med Paper Semi-Annual Data
Net Cash per Share
CAS:MDP vs SLVM: Net Cash per Share Comparison
For the Paper & Paper Products subindustry, Med Paper's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Paper Price-to-Net-Cash vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, Med Paper's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Med Paper's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Med Paper's Net Cash per Share for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Paper (CAS:MDP) has a Net Cash per Share of MAD0.00 as of . 20. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Med Paper and its competitors. According to the industry distribution chart, Med Paper ranks #999999 out of 34 companies in the Forest Products industry.
Is Med Paper's Net Cash per Share too high?
Med Paper's current Net Cash per Share is MAD0.00. Based on the distribution chart, Med Paper ranks #999999 out of 34 companies in the Forest Products industry, which is in the bottom quartile relative to peers.
How does Med Paper's Net Cash per Share compare to SLVM?
According to the Forest Products industry distribution chart, Med Paper ranks #999999 out of 34 companies for Net Cash per Share. This places Med Paper in the lower half of its industry. The industry median Net Cash per Share is 5.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Forest Products company?
The median Net Cash per Share among Forest Products companies is 5.49, based on 34 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Med Paper and its competitors. For the Forest Products industry, the median Net Cash per Share is 5.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Paper's current Net Cash per Share is MAD0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Paper stock overvalued right now?
Med Paper (CAS:MDP) has a current Net Cash per Share of MAD0.00. The current Net Cash per Share is MAD0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Med Paper (CAS:MDP), the current Net Cash per Share is MAD0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:MDP has been successfully added to your 
